S&P/ASX 200 Index (ASX: XJO) shares are in the red on Friday, down 0.1% to 8,628.2 points.
Brokers have reduced their ratings on several stocks this week.
Let’s take a look.
CSL Ltd (ASX: CSL)
The CSL share price is $97.98, up 0.7% today.
Over the past month, this ASX 200 healthcare share has fallen another 30%.
Jarden downgraded CSL shares from a buy to hold rating on Tuesday.
The broker slashed its 12-month price target from $244 to $191.
This still suggests major potential upside of 95% over the next 12 months.
GrainCorp Ltd (ASX: GNC)
The Graincorp share price is $5.23, down 2.9% and down 20% over the past month.
Morgans downgraded this ASX 200 agribusiness share after the company released its 1H FY26 results.
The broker moved to a hold rating with a $5.62 target, implying 7.5% upside ahead.
In a note, the broker said:
GNC’s 1H26 result was weak but broadly in line with consensus at the NPAT level. Business unit performance was stronger for Agribusiness but materially weaker for Nutrition & Energy given a one-off derivate timing issue.
GNC reported a significantly larger than expected cash outflow and its core cash position was also lower than expected.
The era of special dividends now appears to be over. GNC reiterated its FY26 earnings guidance.
Looking ahead to FY27, Morgans said dry El Nino conditions and cost pressures would likely lead to a “much smaller crop”.
GNC’s strategic assets are worth materially more than its current share price.
However, given earnings look set to decline again in FY27, the stock is lacking share price catalysts, and we move to a HOLD recommendation.
Healius Ltd (ASX: HLS)
The Healius share price is 37 cents, down 1.4% on Friday.
Over the past five trading days, this ASX healthcare stock has fallen 27%.
Healius shares were smashed after the company issued an FY26 earnings downgrade.
RBC Capital downgraded Healius shares to a sell rating this week.
The broker slashed its 12-month price target from 75 cents to 35 cents.
This indicates the stock is fully priced.
Amotiv Ltd (ASX: AOV)
The Amotiv share price is $6.25, up 0.2% today.
Over the past six months, this ASX consumer discretionary share has fallen 30%.
Citi downgraded Amotiv shares to a hold rating on Tuesday.
The broker slashed its price target from $9.30 to $6.70, indicating limited upside ahead.
Mach7 Technologies Ltd (ASX: M7T)
The Mach7 Technologies share price is 28 cents, up 1.8% today.
In the calendar year to date, this ASX healthcare share has tumbled 59%.
Canaccord Genuity downgraded Mach7 shares to a hold rating with a 27-cent target on Tuesday.
This suggests the stock is fully priced.
The post 5 ASX shares downgraded by brokers this week appeared first on The Motley Fool Australia.
Should you invest $1,000 in CSL right now?
Before you buy CSL shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Why CBA, Paladin Energy and CSL shares crashed 9% to 17% this week
- CSL shares vs CBA shares: Which is the better buy?
- Buy, hold, sell: Aristocrat, Breville, and Healius shares
- Down 30%: Is this ASX 200 stock a buy after its crash?
- 5 things to watch on the ASX 200 on Friday
Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Mach7 Technologies. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.